Depressive Disorder, MajorDepressive DisorderNMRA-335140
Dr. Elizabeth Zarate-Rowell, MD
NPI1992830236PAC ID7214121565
- Part D claims, 2024
- 669
- Clinical trials
- 6
- Industry payments
- $13,621
- Affiliated sites
- 1
- Medical group
- 1
- Practice address
- 5190 Atlantic Ave, Long Beach, CA 90805
- Practice phone
- Call (818) 996-1051
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Tarzana Treatment Centers
FQHC - Main Site · Long Beach, California
Find Dr. Zarate-Rowell's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Elizabeth Zarate-Rowell is a psychiatrist in Long Beach, California
Dr. Zarate-Rowell practices at Tarzana Treatment Centers in Long Beach, California.
Dr. Zarate-Rowell's NPI, 1992830236, was assigned on February 23, 2007. Dr. Zarate-Rowell holds California license 0A53142.
NPI and contact details
- NPI
- 1992830236NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7214121565
- NPI enumeration date
- February 23, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (818) 996-1051
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 75
- Medical school graduation
- 1977
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Elizabeth Zarate-Rowell practices at Tarzana Treatment Centers in Long Beach, California
Dr. Zarate-Rowell's primary practice is Tarzana Treatment Centers, at 5190 Atlantic Ave, Long Beach, CA 90805. The practice phone is (818) 996-1051.
- Tarzana Treatment Centers5190 Atlantic Ave, Long Beach, CA 90805Phone(818) 996-1051
Source: Dmand AI Affiliation Data
Dr. Elizabeth Zarate-Rowell is affiliated with 1 site of care and 1 medical group
Dr. Zarate-Rowell's primary practice is Tarzana Treatment Centers in Long Beach, California. The medical group on file is Tarzana Treatment Centers. Dr. Zarate-Rowell's employer is on file too: a community health center (fqhc).
Tarzana Treatment CentersPrimary
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Elizabeth Zarate-Rowell's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zarate-Rowell practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Tarzana Treatment Centers | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Zarate-Rowell practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Elizabeth Zarate-Rowell is one of 6,803 psychiatrists in California
Psychiatry is Dr. Zarate-Rowell's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Zarate-Rowell is licensed in California.
Specialties and state licenses
- Psychiatry, CaliforniaPrimary
Psychiatrists near Dr. Zarate-Rowell
Counts of psychiatrists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Elizabeth Zarate-Rowell's patients have a median age of 38
Across all payers, Dmand AI patient panel data puts Dr. Zarate-Rowell's median patient age at 38, with 37% women.
Dr. Zarate-Rowell's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 38
Patient panel by sex, all payers
- Women37%
- Men63%
Source: Dmand AI Patient Panel Data
Dr. Elizabeth Zarate-Rowell wrote 669 Medicare Part D claims in 2024
In 2024, Dr. Zarate-Rowell wrote 669 Medicare Part D claims for 63 patients. 82% of them were for generic drugs. CMS names the drug for 511 of them, across 19 drugs with 11 or more claims each, at $337,162 in total drug cost.
Part D claims, 2024669
Drugs named by CMS19
Total drug cost$337,162
Part D patients63
Dr. Zarate-Rowell's Part D claims by kind of drug, 2024
- Generic547 claims82%
- Brand-name122 claims18%
Dr. Zarate-Rowell's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Zarate-Rowell's Part D claims, 2024
- Antipsychotics, patients 65 and over19%126 of 669 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Elizabeth Zarate-Rowell takes part in Medicare
Dr. Zarate-Rowell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find psychiatrists like Dr. Zarate-Rowell by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Elizabeth Zarate-Rowell has worked on 6 clinical trials
Dmand AI links Dr. Zarate-Rowell to 6 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Alzheimer Disease, Tauopathies and Attention Deficit Disorder with Hyperactivity. Open Payments lists research payments to Dr. Zarate-Rowell that name 1 trial.
Clinical trials with Dr. Zarate-Rowell by phase
- NonePhase 1: no trials
- 3Phase 2: 3 trials
- 1Phase 2/3: 1 trial
- NonePhase 3: no trials
- 1Phase 4: 1 trial
Conditions in Dr. Zarate-Rowell's trials
- Alzheimer Disease
- Tauopathies
- Attention Deficit Disorder with Hyperactivity
- Depressive Disorder, Major
- Plaque, Amyloid
Investigators on the most trials with Dr. Zarate-Rowell
- Gustavo Alva, MD2 shared trials
- David M. Bear, DO2 shared trials
- Mohammad R. Bolouri, MD2 shared trials
Recent clinical trials with Dr. Zarate-Rowell
Alzheimer DiseaseTauopathiesBPN14770
Alzheimer DiseaseTauopathiesNeflamapimod
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) (opens in a new tab)
CompletedPhase 4
Attention Deficit Disorder with HyperactivityAttention Deficit and Disruptive Behavior DisordersAtomoxetine hydrochlorideGuanfacine hydrochloride (TAK-503)
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen® (opens in a new tab)
TerminatedPhase 2/3
SchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersNaBen®
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Elizabeth Zarate-Rowell received $13,621 in industry payments from 2024 to 2025
CMS Open Payments shows 301 general payments to Dr. Zarate-Rowell from 15 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 82% of the total. Neurocrine BioSciences, Inc. paid the most, $2,151. It also lists 5 research payments totaling $1,492 in 2025, naming 1 clinical trial.
General payments to Dr. Zarate-Rowell by program year, 2024 to 2025
General payments to Dr. Zarate-Rowell by kind, 2024 to 2025
$13.6Kin total
- Food and beverage$11,22782%
- Travel and lodging$2,19316%
- Education$2021%
Companies that paid Dr. Zarate-Rowell the most, 2024 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Elizabeth Zarate-Rowell's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Elizabeth Zarate-Rowell
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Elizabeth Zarate-Rowell's NPI number?
Dr. Elizabeth Zarate-Rowell's NPI number is 1992830236. It was assigned on February 23, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Elizabeth Zarate-Rowell?
Dr. Elizabeth Zarate-Rowell is a psychiatrist in Long Beach, California. The primary specialty in the NPI Registry is Psychiatry Physician (taxonomy code 2084P0800X).
Where does Dr. Elizabeth Zarate-Rowell practice?
Dr. Zarate-Rowell practices at 5190 Atlantic Ave, Long Beach, CA 90805. Dr. Zarate-Rowell's primary practice is Tarzana Treatment Centers in Long Beach, California.
What is Dr. Elizabeth Zarate-Rowell's office phone number?
The practice phone on file for Dr. Zarate-Rowell is (818) 996-1051.
What is Dr. Elizabeth Zarate-Rowell's medical license number?
Dr. Zarate-Rowell holds California license 0A53142.
What medical group is Dr. Elizabeth Zarate-Rowell part of?
Dr. Zarate-Rowell is linked to Tarzana Treatment Centers.
Does Dr. Elizabeth Zarate-Rowell accept Medicare?
Yes. CMS lists Dr. Zarate-Rowell as accepting Medicare assignment.
What drugs does Dr. Elizabeth Zarate-Rowell prescribe most?
In 2024 Medicare Part D data, Dr. Zarate-Rowell's most prescribed drugs by claims were Clozapine, Gabapentin and Propranolol HCl.
Has Dr. Elizabeth Zarate-Rowell received payments from drug or device companies?
CMS Open Payments shows $13,621 in general payments to Dr. Zarate-Rowell from 15 companies from 2024 to 2025. The largest total came from Neurocrine BioSciences, Inc.
How long has Dr. Elizabeth Zarate-Rowell been practicing?
Dr. Zarate-Rowell graduated from medical school in 1977, 49 years ago.
Does Dr. Elizabeth Zarate-Rowell do research?
Dr. Zarate-Rowell has worked on 6 clinical trials.
Selling to psychiatry practices?
See psychiatrists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card